PATHWAY Details

Gene Name Gene ID KEGG ID Pathway Name EC No.
KLRT323882 - -  -
KLRT323845 hsa04010 MAPK signaling pathway  -
KLRT323845 hsa04012 ErbB signaling pathway  -
KLRT323845 hsa04062 Chemokine signaling pathway  -
KLRT323845 hsa04320 Dorso-ventral axis formation  -
KLRT323845 hsa04360 Axon guidance  -
KLRT323845 hsa04370 VEGF signaling pathway  -
KLRT323845 hsa04530 Tight junction  -
KLRT323845 hsa04540 Gap junction  -
KLRT323845 hsa04650 Natural killer cell mediated cytotoxicity  -
KLRT323845 hsa04660 T cell receptor signaling pathway  -
KLRT323845 hsa04662 B cell receptor signaling pathway  -
KLRT323845 hsa04664 Fc epsilon RI signaling pathway  -
KLRT323845 hsa04720 Long-term potentiation  -
KLRT323845 hsa04722 Neurotrophin signaling pathway  -
KLRT323845 hsa04730 Long-term depression  -
KLRT323845 hsa04810 Regulation of actin cytoskeleton  -
KLRT323845 hsa04910 Insulin signaling pathway  -
KLRT323845 hsa04912 GnRH signaling pathway  -
KLRT323845 hsa04914 Progesterone-mediated oocyte maturation  -
KLRT323845 hsa04916 Melanogenesis  -
KLRT323845 hsa04960 Aldosterone-regulated sodium reabsorption  -
KLRT323845 hsa05160 Hepatitis C  -
KLRT323845 hsa05200 Pathways in cancer  -
KLRT323845 hsa05210 Colorectal cancer  -
KLRT323845 hsa05211 Renal cell carcinoma  -
KLRT323845 hsa05212 Pancreatic cancer  -
KLRT323845 hsa05213 Endometrial cancer  -
KLRT323845 hsa05214 Glioma  -
KLRT323845 hsa05215 Prostate cancer  -
KLRT323845 hsa05216 Thyroid cancer  -
KLRT323845 hsa05218 Melanoma  -
KLRT323845 hsa05219 Bladder cancer  -
KLRT323845 hsa05220 Chronic myeloid leukemia  -
KLRT323845 hsa05221 Acute myeloid leukemia  -
KLRT323845 hsa05223 Non-small cell lung cancer  -